NCT00984516View on ClinicalTrials.gov

Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
CicatrixWound-healing
Interventions
DRUG

Juvidex

Intradermal Juvidex, 100μl of 100mM (2.82mg/100μl) administered once prior to wounding

DRUG

Juvidex

Intradermal Juvidex, 100μl of 100mM (2.82mg/100μl) administered once prior to wounding, once 3 hours later at 100μl/wound margin (200μl total) and again on Day 5 (200μl)

DRUG

Juvidex

Intradermal Juvidex, 100μl of 200mM (5.64mg/100μl) administered once prior to wounding

DRUG

Juvidex

Intradermal Juvidex, 100μl of 200mM (5.64mg/100μl) administered once prior to wounding, once 3 hours later at 100μl/wound margin (200μl total) and again on Day 5 (200μl)

DRUG

Juvidex

Intradermal Juvidex, 100μl of 400mM (11.28mg/100μl) administered once prior to wounding

DRUG

Juvidex

Intradermal Juvidex, 100μl of 400mM (11.28mg/100μl) administered once prior to wounding, once 3 hours later at 100μl/wound margin (200μl total) and again on Day 5 (200μl)

DRUG

Placebo

Intradermal Placebo, 100μl administered once prior to wounding

DRUG

Placebo

Intradermal Placebo, 100μl administered once prior to wounding, once 3 hours later at 100μl/wound margin (200μl total) and again on Day 5 (200μl)

Trial Locations (1)

M13 9XX

Renovo, Manchester

All Listed Sponsors
lead

Renovo

INDUSTRY

NCT00984516 - Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times | Biotech Hunter | Biotech Hunter